Exogenous estrogen exposures and changes in diabetic retinopathy: The Wisconsin Epidemiologic Study of Diabetic Retinopathy

Diabetes Care

Volumn 22, Issue 12, 1999, Pages 1984-1987

  Klein, Barbara E K ^a,b   Klein, Ronald ^a   Moss, Scot E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORRELATION FUNCTION; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE SEVERITY; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; RETINA MACULA EDEMA;

EID: 0033364365     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.12.1984     Document Type: Article

References (29)

1. Klein BEK, Moss SE, Klein R: Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 13:34-40, 1940
2. Klein BEK, Moss SE, Klein R: Is menarche associated with diabetic retinopathy? Diabetes Care 13:1034-1038, 1990
3. Jackson RL, Ide GH, Guthrie RA, James RD: Retinopathy in adolescents and young adults with onset of insulin-dependent diabetes in childhood. Ophthalmology 89:7-13, 1982
4. Bradley DD, Wingerd J, Petitti DB, Krauss RM, Ramcharan S: Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med 299:17-20, 1978
5. Wynn V: Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism. Am J Obstet Gynecol 142:739-746, 1982
6. Fisch IR, Frank J: Oral contraceptives and blood pressure. JAMA 237:2499-2503, 1977
7. Miller VT: Lipids, lipoproteins, women and cardiovascular disease. Atherosclerosis 108 (Suppl. I):S73-S82, 1994
8. Espeland MA, Hogan PE, Fineberg SE, Howard G, Schrott H, Waclawiw MA, Bush TL: Effect of postmenopausal hormone therapy on glucose and insulin concentrations: PEPI Investigators: Postmenopausal Estrogen/Progestin Interventions. Diabetes Care 21:1589-1595, 1998
9. Belfort MA, Saade GR, Snabes M, Dunn R, Moise KJ Jr, Cruz A, Young R: Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 172:1273-1278, 1995
10. Brussaard HE, Gevers Leuven JA, Kluft C, Krans HM, van Duyvenvoorde W, Buytenhek R, van der Laarse A, Princen HM: Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus. Arterioscler Thomb Vasc Biol 17:324-330, 1997
11. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280:605-613, 1998
12. Weiss NS, Szekely DR, English DR, Schweid AI: Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA 242:261-264, 1979
13. Risch HA, Howe GR: Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. Am J Epidemiol 139:670-683, 1994
14. The Writing Group for the PEPI: Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 276:1389-1396, 1996
15. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH: A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313:1044-1049, 1985
16. Klein BEK, Moss SE, Klein R: Oral contraceptives in women with diabetes. Diabetes Care 13:895-898, 1990
17. Klein R, Klein BEK, Moss SE, DeMets DL, Kaufman I, Voss PS: Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol 119:54-61, 1984
18. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
19. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 107:237-243, 1989
20. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112:1217-1228, 1994
21. Hypertension Detection and Follow-Up Program Cooperative Group: The Hypertension Detection and Follow-Up Program. Prev Med 5:207-215, 1976
22. Early Treatment Diabetic Retinopathy Study Research Group: Manual of Operations, Baltimore, MD, ETDRS Coordinating Center, Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, 1985
23. Quick-Step: Fast Hemoglobin Test System. Akron, OH, Isolab, 1981
24. Drug Facts and Comparisons. St. Louis, MO, Facts and Comparisons, 1999
25. Klein R, Klein BEK, Magli YE, Brothers RJ, Meuer SM, Moss SE, Davis MD: An alternative method of grading diabetic retinopathy. Ophthalmology 93:1183-1187, 1986
26. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
27. Mantel N: Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58:690-700, 1963
28. Hosmer DW Jr, Lemeshow S: Chapter 8. Applied Logistic Regression. New York, Wiley, 1989, p. 238-245
29. The Women's Health Initiative Study Group: Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials 19:61-109, 1998